Christian Tang-Jespersen

Treon is a global leader in AI‑driven Smart Industry technologies, enabling industrial organizations to boost productivity, enhance operational visibility, and strengthen long‑term sustainability. Our fully integrated Predictive Maintenance cloud solutions bring together advanced self‑learning AI analytics, a mobile‑first user experience, automated workflows, and wireless vibration sensors—delivered through a true pay‑as‑you‑go subscription model. Today, Treon supports more than 200 customers worldwide across the manufacturing, material handling, and logistics sectors, helping them transition from reactive operations to intelligent, predictive performance.

At Again we put CO₂ to good use. By combining millennia-old bacteria with cutting-edge technology, we turn CO₂ into carbon negative chemicals. Our novel biomanufacturing process collects the unavoidable carbon outputs from industry and reuses them to manufacture emission-free chemicals - a win-win for everyone. We’re leading the positive shift. Showing people that our world does have a future. If you think we’re doomed – think Again.

Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals. We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.

Invert is Bioprocess AI Software that transforms fragmented data into a living knowledge base – one that gets smarter with every run, batch, and experiment. By connecting data across instruments, systems, and CDMOs, Invert delivers the compounding scientific intelligence teams need to make faster, more confident decisions and bring life-changing therapies to market sooner. Biotech, pharma, and manufacturing companies around the world rely on Invert to reduce uncertainty, accelerate development and scale-up, and deliver life-saving therapies and sustainable products faster.

Blumind is bringing machine-learning inferencing to the Far Edge, placing it on devices and sensors in all environments. Future applications in Edge AI such as IoT, automotive, Smart Home and Smart City will be crippled by the power and latency constraints of current digital technologies. Blumind’s breakthrough all-analog, in-memory inferencing engine slashes power consumption, latency and silicon area all by orders of magnitude versus digital approaches.

Uhnder develops disruptive products for sensing, cognition, and communication.

Nordsense is on a mission to redefine the waste management industry with smart sensors and data. We believe a data-driven approach is the key to kickstarting a smart waste management revolution and making waste collection greener, cleaner, and smarter. With almost 90% of the world’s waste collected at the wrong time, Nordsense was born out of a desire to address the inefficiency and lack of sustainability in traditional waste management. The Silicon Valley funded start-up was established in 2015 in Denmark and offers a complete end-to-end waste optimization solution based on IoT sensor technology for cities, municipalities, waste operators, collectors, haulers, facility management, and campuses in Europe, Israel, and North America.

DenmarkBridge is a membership-driven initiative, consisting of Danish corporations with a shared interest in exploring the opportunities that flow from the ever-changing technological developments. DenmarkBridge aims at bridging the gap between Danish companies and Silicon Valley by creating a community consisting of high-level strategic networking and knowledge sharing among like-minded business partners. DenmarkBridge is a public-private non-profit initiative founded on the acknowledgement that strategic networking is a key ingredient in understanding, adapting and developing disruptive innovations. DenmarkBridge aims at bringing disruptive startups, investors and large corporations together across the Atlantic through strategic, high-level networking and knowledge sharing.

SES is developing a Mine-to-Man AI software system for Li-Metal batteries. Born, bred and headquartered in Boston, it has operations in Boston, Shanghai and Seoul.

Treon is a global leader in AI‑driven Smart Industry technologies, enabling industrial organizations to boost productivity, enhance operational visibility, and strengthen long‑term sustainability. Our fully integrated Predictive Maintenance cloud solutions bring together advanced self‑learning AI analytics, a mobile‑first user experience, automated workflows, and wireless vibration sensors—delivered through a true pay‑as‑you‑go subscription model. Today, Treon supports more than 200 customers worldwide across the manufacturing, material handling, and logistics sectors, helping them transition from reactive operations to intelligent, predictive performance.

At Again we put CO₂ to good use. By combining millennia-old bacteria with cutting-edge technology, we turn CO₂ into carbon negative chemicals. Our novel biomanufacturing process collects the unavoidable carbon outputs from industry and reuses them to manufacture emission-free chemicals - a win-win for everyone. We’re leading the positive shift. Showing people that our world does have a future. If you think we’re doomed – think Again.

Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals. We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.

Invert is Bioprocess AI Software that transforms fragmented data into a living knowledge base – one that gets smarter with every run, batch, and experiment. By connecting data across instruments, systems, and CDMOs, Invert delivers the compounding scientific intelligence teams need to make faster, more confident decisions and bring life-changing therapies to market sooner. Biotech, pharma, and manufacturing companies around the world rely on Invert to reduce uncertainty, accelerate development and scale-up, and deliver life-saving therapies and sustainable products faster.

Blumind is bringing machine-learning inferencing to the Far Edge, placing it on devices and sensors in all environments. Future applications in Edge AI such as IoT, automotive, Smart Home and Smart City will be crippled by the power and latency constraints of current digital technologies. Blumind’s breakthrough all-analog, in-memory inferencing engine slashes power consumption, latency and silicon area all by orders of magnitude versus digital approaches.